Novartis AG (NVS) — Financial statements
Income statement, balance sheet, and cash flow for Novartis AG — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 54,811↑6.0% | 51,722↑10.8% | 46,660↑7.4% | 43,461↓1.2% | 43,974 | |
| Cost of Revenue | 13,690↑6.7% | 12,827↑2.8% | 12,472↑7.7% | 11,582↓1.3% | 11,735 | |
| Gross Profit | 41,122↑5.7% | 38,895↑13.8% | 34,188↑7.2% | 31,879↓1.1% | 32,239 | |
| Operating Expenses | ||||||
| R&D Expenses | 10,742↑7.2% | 10,022↓11.9% | 11,371↑24.0% | 9,172↑6.1% | 8,641 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 13,306↑5.9% | 12,566↑0.4% | 12,517↑2.7% | 12,193↓4.9% | 12,827 | |
| Other Expenses | 0.00↓100.0% | 1,763↑232.0% | 531↓79.3% | 2,568↑259.2% | 715 | |
| Operating Expenses | 24,048↓1.2% | 24,351↓0.3% | 24,419↑2.0% | 23,933↑7.9% | 22,183 | |
| Total Costs & Expenses | 37,737↑1.5% | 37,178↑0.8% | 36,891↑3.9% | 35,515↑4.7% | 33,918 | |
| Operating Results | ||||||
| Operating Income | 17,074↑17.4% | 14,544↑48.9% | 9,769↑22.9% | 7,946↓21.0% | 10,056 | |
| Depreciation & Amortization | 5,352↓11.8% | 6,069↓26.7% | 8,277↑23.4% | 6,705↑19.8% | 5,597 | |
| EBITDA | 22,987↑11.0% | 20,715↑13.5% | 18,255↑24.3% | 14,682↓52.5% | 30,914 | |
| EBIT | 17,635↑20.4% | 14,646↑46.8% | 9,978↑25.1% | 7,977↓68.5% | 25,317 | |
| Interest & Other Income | ||||||
| Net Interest Income | -812↓73.3% | -469↓89.9% | -247↑46.0% | -457↑45.2% | -834 | |
| Interest Income | 375↓34.0% | 568↓9.8% | 629↑66.6% | 378↑432.0% | 71 | |
| Interest Expense | 1,187↑14.5% | 1,036↑18.3% | 876↑5.0% | 835↓7.8% | 905 | |
| Non-Operating Income | -561↓449.9% | -102↑51.2% | -209↓574.2% | -31↑99.8% | -15,261 | |
| Other Income / Expenses | -638↑29.4% | -904↓39.9% | -646↑16.0% | -769↓105.3% | 14,474 | |
| Income Before Tax | 16,436↑20.5% | 13,640↑49.5% | 9,123↑27.1% | 7,177↓70.7% | 24,530 | |
| Income Tax Expense | 2,397↑40.9% | 1,701↑208.7% | 551↓51.2% | 1,128↓30.6% | 1,625 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 14,039↑17.6% | 11,939↑39.3% | 8,572↑41.7% | 6,049↓73.6% | 22,905 | |
| Net Income from Discontinued Operations | 0.00 | 0.00↓100.0% | 6,282↑593.4% | 906↓18.6% | 1,113 | |
| Net Income | 14,056↑17.7% | 11,941↓19.6% | 14,850↑113.5% | 6,955↓71.0% | 24,021 | |
| Bottom-Line Net Income | 14,056↑17.7% | 11,941↓19.6% | 14,850↑113.5% | 6,955↓71.0% | 24,021 | |
| EPS (Basic) | 7.25↑22.5% | 5.92↓17.2% | 7.15↑124.1% | 3.19↓70.2% | 10.71 | |
| EPS (Diluted) | 7.19↑22.5% | 5.87↓17.3% | 7.10↑124.0% | 3.17↓70.2% | 10.63 | |
| Weighted Average Shares | 1,939↓3.9% | 2,018↓2.8% | 2,077↓4.8% | 2,181↓2.7% | 2,243 | |
| Weighted Average Diluted Shares | 1,955↓3.9% | 2,035↓2.7% | 2,092↓4.8% | 2,197↓2.8% | 2,260 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.